Novel strategy for allergenicity risk assessment of proteins in regulated food and feed products
Buyer
NameEuropean Food Safety Authority
CountryIT
Published2026-06-22
Deadline2026-06-30
Value
Estimated€1,300,000 · 1,300,000 EUR
Awarded—
CPV codes
73000000 Research & development servicesDescription
The aim of this call is to seek support for the development of a novel strategy for allergenicity risk assessment (RA) of proteins in food and feed. For both clinically-relevant cross-reactivity and de novo sensitisation, the project foresees the development of open source in silico prediction/appraisal tools to be validated with experimental data; assessment of future prospects for in silico tools; estimation of thresholds of allergological concern, and the development of a systematic tiered approach with a decision-making framework. This novel strategy will enhance the reliability and speed of allergenicity RA and support process simplification and harmonisation, ultimately enabling better-informed risk management decision-making.
Similar tenders
Closest by meaning — across languages, via embeddings.
| Published | Title | Buyer | Match |
|---|---|---|---|
| 2026-05-19 | Metagenomics Adoption in EFSA Risk Assessment | European Food Safety Authority IT | 86% |
| 2026-06-12 | Emerging risk Identification through analysis of botanical substances in food supplements | European Food Safety Authority IT | 86% |
| 2026-06-24 | Long-term API stockpiling and rapid finished dose form manufacture | Health and Digital Executive Agency (HaDEA) , HADEA - Health and Digital Executive Agency BE | 85% |
| 2026-06-08 | Nanomaterial Risk Assessment: Refining and Validating Acceptable Variation in Nanoform Characterisers | European Chemicals Agency FI | 85% |
| 2026-05-20 | REAGENTI IN LABORATORIJSKI MATERIAL ZA IZVAJANJE PREISKAV NA ANALIZATORJU ZA NEFELOMETRIČNO DOLOČANJE PROTEINOV | UNIVERZITETNI KLINIČNI CENTER MARIBOR SI | 85% |
| 2026-06-12 | REAGENTI IN LABORATORIJSKI MATERIAL ZA IZVAJANJE PREISKAV NA ANALIZATORJU ZA NEFELOMETRIČNO DOLOČANJE PROTEINOV | UNIVERZITETNI KLINIČNI CENTER MARIBOR SI | 85% |